A. “Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease,” by Hector De Jesus-Cortes, Pin Xu, Jordan Drawbridge, Sandi Jo Estill, Paula Huntington, Stephanie Tran, Jeremiah Britt, Rachel Tesla, Lorraine Morlock, Jacinth Naidoo, Lisa M. Melito, Gelin Wang, Noelle S. Williams, Joseph M. Ready, Steven L. McKnight, and Andrew A. Pieper (Vol. 109, No. 42, October 16, 2012, .pdf and HTML format, p. 17010-17015). Note: PNAS is providing open access to the full-text of this article.
www.pnas.org/content/109/42/17010.abstract.html?etoc
B. “Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model,” by Pascal E. Sanchez, Lei Zhu, Laure Verret, Keith A. Vossel, Anna G. Orr, John R. Cirrito, Nino Devidze, Kaitlyn Ho, Gui-Qiu Yu, Jorge J. Palop, and Lennart Mucke (Vol. 109, No. 42, October 16, 2012, .pdf and HTML format, p. E2895-E2903). Note: PNAS is providing open access to the full-text of this article.
